References
- Pallud J, Devaux B, Nataf F, Roux FX, Daumas-Duport C. Spatial delimitation of low grade oligodendrogliomas. Neurochirurgie 2005; 51: 253-9.
- Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys 2004; 59: 126-37.
- Walecki J, Tarasow E, Kubas B, Czemicki Z, Lewko J, Podgorski J., et al. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. Acad Radiol 2003; 10: 145-53.
- Chang J, Thakur S, Perera G, Kowalski A, Huang W, Karimi S., et al. Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys 2006; 33: 32-40.
- McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 2001; 13: 167-77.
- Hunjan S, Adalsteinsson E, Kim DH, Harsh GR, Boyer AL, Spielman D., et al. Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data. Int J Radiat Oncol Biol Phys 2003; 57: 1159-73.
- Woo DC, Kim BS, Jung SL, Park HJ, Rhim HS, Jahng GH., et al. Develpment of a cone-shaped phantom for multi-voxel MR scpectroscopy. J Neurosci Methods 2007; 162: 101-7.
- Rice JR, Milbrandt RH, Madsen EL, Frank GR, Boote EJ, Blenchinger JC. Anthromorphic 1H MRS head phantom. Med Phys 1998; 25: 1145-56.
- Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45: 765-9.
- Drost DJ, Riddle WR, Clarke GD. Proton magnetic resonance spectroscopy in the brain: Report of AAPM Task Group #9. Med Phys 2002; 29: 2177-97.
- Nishimura DG. Principles of magnetic resonance imaging: Stanford: Stanford University; 1996.
- Haacke EM. Magnetic resonance imaging, physics principles and sequence design. New York: John Wiley & Sons; 1999.
- Doddrell DM, Galloway G, Brooks W, Filed J, Bulsing J, Irving M, et al. Water signal elimination in vivo, using suppression by mistimed echo and repetitive gradient episodes. J Magn Reson 1986; 70: 176-80.
- Hasse A, Frahm J, Hanicke W, Mattaei W. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985; 30: 341-4.
- Mierisova S, Ala-Korpela M. MR spectroscopy quantitation: a review of frequency domain methods. NMR Biomed 2001; 14: 247-59.
- Moré JJ. The Levenberg-Marquardt algorithm: implementation and theory. In: GA Watson, editor. Lecture notes in mathematics. Heidelberg: Springer Verlag; 1977. p. 105-16.
- Nelson SJ, Graves E, Pirzkall A, Li X, Chan AA, Vigneron DB., et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 2002; 16: 464-76.
- Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 2007; 80: 347-54.
- Jeun SS, Kim MC, Kim BS, Lee JM, Chung ST, Oh CH, et al. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy. J Clin Imaging 2005; 29: 10-5.